Results for tag: "Neuroblastoma Drug"

Neuroblastoma is a type of cancer that affects the nervous system, primarily in children. It is the most common type of extracranial solid tumor in children and accounts for approximately 15% of all childhood cancers. Treatment for neuroblastoma typically involves a combination of surgery, chemotherapy, radiation therapy, and immunotherapy. Oncology drugs are used to treat cancer, and the neuroblastoma drug market is a subset of the larger oncology drug market. The neuroblastoma drug market is composed of a variety of drugs, including monoclonal antibodies, small molecule drugs, and immunotherapies. These drugs are used to treat neuroblastoma in both children and adults. The market is expected to grow due to the increasing prevalence of neuroblastoma and the development of new treatments. Some companies in the neuroblastoma drug market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. These companies are involved in the development and commercialization of drugs for the treatment of neuroblastoma. Show Less Read more